PanSarb Vaccine Toxicology Study

Tender details

The University of Saskatchewan needs a qualified CRO to perform a GLP-compliant repeat-dose toxicology study supporting a PanSarb vaccine Phase 1 clinical trial application to Health Canada. The contractor must conduct regulated preclinical testing, generate study data, and provide results suitable for submission in a first-in-human development package.